News

 

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine
Recreación de un cáncer de pulmón de células pequeñas
ORYZON announces first patient dosed in an Investigator-initiated Phase Ib study of iadademstat in extensive stage small cell lung cancer
Healthcare · Innovative drugs
The study, led by Yale University, explore the combination with atezolizumab and radiation therapy.
Partners - Oryzon Genomics
Profesor Ignacio Martín-Loeches
Viva In Vitro appoints Professor Ignacio Martín-Loeches to its Medical Advisory Board, strengthening its international clinical leadership in sepsis
Healthcare · Talento
Dr Ignacio Martín-Loeches joins Viva In Vitro Diagnostics as an advisor to its Medical Advisory…
Partners - VIVA IN VITRO
Gráfico que muestra los indicadores de Génesis Biomed
GENESIS Biomed closes 2025 with record growth and greater impact on the biomedical ecosystem
Corporate
GENESIS Biomed closes 2025 as its best year ever, with strong growth compared to 2024: 506 projects…
Partners - GENESIS Biomed
sede oryzon
ORYZON strengthens patent portfolio for vafidemstat with new Decision to Grant in Japan
Healthcare · Industrial biotechnology
For the treatment of aggression and social withdrawal.
Partners - Oryzon Genomics
Logo de N-GENE
When genetics does not change, but science does. The challenge of keeping genetic health information up to date
Healthcare · Personalized medicine
A person's genetics do not change throughout their life. What does change, and does so constantly,…
Partners - ADNTRO GENETICS SL
Jóvenes emprendedores
The need to promote entrepreneurship among young people
Talento
Youth entrepreneurship emerges as a natural response to a changing environment, where young people…
Partners - GENESIS Biomed
Natac incrementa un 66,5% su EBITDA en 2025, hasta superar los 23 millones
Natac increases its EBITDA by 66.5% in 2025, surpassing €23 million
Corporate
The figure is significantly above the €20 million previously forecast and communicated to the…
Partners - Natac Group
Laboratorio de Archivel Farma
Archivel Farma renews GMP certification and strengthens its transformation into a CDMO
Healthcare · Access to innovation
The GMP renewal is the result of a comprehensive process to upgrade the facilities, manufacturing…
Partners - Archivel Farma
Camillas de hospital
The future of Clinical Trials
Healthcare · Access to innovation
Digital transformation and artificial intelligence are redefining the traditional model of clinical…
Partners - GENESIS Biomed